These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

386 related items for PubMed ID: 9001706

  • 1. L-deprenyl fails to protect mesencephalic dopamine neurons and PC12 cells from the neurotoxic effect of 1-methyl-4-phenylpyridinium ion.
    Vaglini F, Pardini C, Cavalletti M, Maggio R, Corsini GU.
    Brain Res; 1996 Nov 25; 741(1-2):68-74. PubMed ID: 9001706
    [Abstract] [Full Text] [Related]

  • 2. Attenuation of 1-methyl-4-phenylpyridinium (MPP+) neurotoxicity by deprenyl in organotypic canine substantia nigra cultures.
    Schmidt DE, Ebert MH, Lynn JC, Whetsell WO.
    J Neural Transm (Vienna); 1997 Nov 25; 104(8-9):875-85. PubMed ID: 9451719
    [Abstract] [Full Text] [Related]

  • 3. Protection from 1-methyl-4-phenylpyridinium (MPP+) toxicity and stimulation of regrowth of MPP(+)-damaged dopaminergic fibers by treatment of mesencephalic cultures with EGF and basic FGF.
    Park TH, Mytilineou C.
    Brain Res; 1992 Dec 18; 599(1):83-97. PubMed ID: 1362921
    [Abstract] [Full Text] [Related]

  • 4. Effect of MAO-B inhibitors on MPP+ toxicity in Vivo.
    Wu RM, Chen RC, Chiueh CC.
    Ann N Y Acad Sci; 2000 Dec 18; 899():255-61. PubMed ID: 10863544
    [Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6. Antioxidant mechanism and protection of nigral neurons against MPP+ toxicity by deprenyl (selegiline).
    Wu RM, Mohanakumar KP, Murphy DL, Chiueh CC.
    Ann N Y Acad Sci; 1994 Nov 17; 738():214-21. PubMed ID: 7832430
    [Abstract] [Full Text] [Related]

  • 7. L-deprenyl protects mesencephalic dopamine neurons from glutamate receptor-mediated toxicity in vitro.
    Mytilineou C, Radcliffe P, Leonardi EK, Werner P, Olanow CW.
    J Neurochem; 1997 Jan 17; 68(1):33-9. PubMed ID: 8978707
    [Abstract] [Full Text] [Related]

  • 8. Differential effects of L-deprenyl on MPP+- and MPTP-induced dopamine overflow in microdialysates of striatum and nucleus accumbens.
    Wu WR, Zhu ZT, Zhu XZ.
    Life Sci; 2000 Jun 08; 67(3):241-50. PubMed ID: 10983868
    [Abstract] [Full Text] [Related]

  • 9. Deprenyl protects dopamine neurons from the neurotoxic effect of 1-methyl-4-phenylpyridinium ion.
    Mytilineou C, Cohen G.
    J Neurochem; 1985 Dec 08; 45(6):1951-3. PubMed ID: 3932598
    [Abstract] [Full Text] [Related]

  • 10. CGP 3466 protects dopaminergic neurons in lesion models of Parkinson's disease.
    Waldmeier PC, Spooren WP, Hengerer B.
    Naunyn Schmiedebergs Arch Pharmacol; 2000 Dec 08; 362(6):526-37. PubMed ID: 11138845
    [Abstract] [Full Text] [Related]

  • 11. Apparent antioxidant effect of l-deprenyl on hydroxyl radical formation and nigral injury elicited by MPP+ in vivo.
    Wu RM, Chiueh CC, Pert A, Murphy DL.
    Eur J Pharmacol; 1993 Oct 26; 243(3):241-7. PubMed ID: 8276076
    [Abstract] [Full Text] [Related]

  • 12. L-Deprenyl and MDL72974 do not improve the recovery of dopaminergic cells following systemic administration of MPTP in mouse.
    Thiffault C, Lamarre-Théroux L, Quirion R, Poirier J.
    Brain Res Mol Brain Res; 1997 Mar 26; 44(2):238-44. PubMed ID: 9073165
    [Abstract] [Full Text] [Related]

  • 13. D-deprenyl protects nigrostriatal neurons against 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine-induced dopaminergic neurotoxicity.
    Muralikrishnan D, Samantaray S, Mohanakumar KP.
    Synapse; 2003 Oct 26; 50(1):7-13. PubMed ID: 12872288
    [Abstract] [Full Text] [Related]

  • 14. (-)-Deprenyl protection of 1-methyl-4 phenylpyridium ion (MPP+)-induced apoptosis independent of MAO-B inhibition.
    Le W, Jankovic J, Xie W, Kong R, Appel SH.
    Neurosci Lett; 1997 Mar 21; 224(3):197-200. PubMed ID: 9131670
    [Abstract] [Full Text] [Related]

  • 15. Deprenyl and desmethylselegiline protect mesencephalic neurons from toxicity induced by glutathione depletion.
    Mytilineou C, Leonardi EK, Radcliffe P, Heinonen EH, Han SK, Werner P, Cohen G, Olanow CW.
    J Pharmacol Exp Ther; 1998 Feb 21; 284(2):700-6. PubMed ID: 9454817
    [Abstract] [Full Text] [Related]

  • 16. The effect of glia-conditioned medium on dopamine neurons in culture. Modulation of apoptosis, tyrosine hydroxylase expression and 1-methyl-4-phenylpyridinium toxicity.
    Mena MA, Casarejos MJ, García de Yébenes J.
    J Neural Transm (Vienna); 1999 Feb 21; 106(11-12):1105-23. PubMed ID: 10651107
    [Abstract] [Full Text] [Related]

  • 17. Caspase inhibitors attenuate 1-methyl-4-phenylpyridinium toxicity in primary cultures of mesencephalic dopaminergic neurons.
    Bilsland J, Roy S, Xanthoudakis S, Nicholson DW, Han Y, Grimm E, Hefti F, Harper SJ.
    J Neurosci; 2002 Apr 01; 22(7):2637-49. PubMed ID: 11923429
    [Abstract] [Full Text] [Related]

  • 18. Relationship between NMDA receptor expression and MPP+ toxicity in cultured dopaminergic cells.
    Church WH, Hewett SJ.
    J Neurosci Res; 2003 Sep 15; 73(6):811-7. PubMed ID: 12949907
    [Abstract] [Full Text] [Related]

  • 19. Deprenyl rescues dopaminergic neurons in organotypic slice cultures of neonatal rat mesencephalon from N-methyl-D-aspartate toxicity.
    Shimazu S, Katsuki H, Akaike A.
    Eur J Pharmacol; 1999 Jul 14; 377(1):29-34. PubMed ID: 10448922
    [Abstract] [Full Text] [Related]

  • 20. Neuronal protective and rescue effects of deprenyl against MPP+ dopaminergic toxicity.
    Wu RM, Murphy DL, Chiueh CC.
    J Neural Transm Gen Sect; 1995 Jul 14; 100(1):53-61. PubMed ID: 8748663
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 20.